Knights of Columbus Asset Advisors LLC Sells 11,661 Shares of Cardinal Health, Inc. $CAH

Knights of Columbus Asset Advisors LLC lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 19.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 47,414 shares of the company’s stock after selling 11,661 shares during the quarter. Knights of Columbus Asset Advisors LLC’s holdings in Cardinal Health were worth $10,550,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CAH. Mesirow Financial Investment Management Inc. boosted its holdings in shares of Cardinal Health by 19.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 1,133 shares of the company’s stock valued at $252,000 after acquiring an additional 186 shares in the last quarter. Cornerstone Wealth Management LLC increased its holdings in Cardinal Health by 72.5% in the 3rd quarter. Cornerstone Wealth Management LLC now owns 6,717 shares of the company’s stock worth $1,494,000 after purchasing an additional 2,824 shares in the last quarter. Vestor Capital LLC increased its holdings in Cardinal Health by 6,855.7% in the 3rd quarter. Vestor Capital LLC now owns 61,906 shares of the company’s stock worth $13,774,000 after purchasing an additional 61,016 shares in the last quarter. Kestra Investment Management LLC raised its position in Cardinal Health by 4.4% in the third quarter. Kestra Investment Management LLC now owns 7,606 shares of the company’s stock valued at $1,692,000 after purchasing an additional 318 shares during the last quarter. Finally, AlphaCore Capital LLC raised its position in Cardinal Health by 52.2% in the third quarter. AlphaCore Capital LLC now owns 7,814 shares of the company’s stock valued at $1,739,000 after purchasing an additional 2,680 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 1.0%

Shares of NYSE:CAH opened at $276.96 on Wednesday. The firm has a market cap of $64.02 billion, a P/E ratio of 35.83, a P/E/G ratio of 1.60 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $180.45 and a 12-month high of $286.29. The business has a fifty day simple moving average of $242.08 and a 200 day simple moving average of $224.22.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, November 5th. The company reported $3.26 EPS for the quarter, beating analysts’ consensus estimates of $2.94 by $0.32. The firm had revenue of $67.51 billion for the quarter, compared to analyst estimates of $66.67 billion. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The business’s revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.55 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 12.96 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on CAH. Evercore reissued an “outperform” rating and set a $270.00 price target on shares of Cardinal Health in a research note on Wednesday, August 12th. Royal Bank Of Canada upped their price objective on Cardinal Health from $276.00 to $295.00 and gave the company an “outperform” rating in a research note on Friday, November 6th. Wells Fargo & Company raised their price objective on shares of Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Citigroup lifted their target price on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. Finally, Barclays boosted their target price on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $275.62.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, insider Jessica Mayer sold 29,436 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the completion of the sale, the insider owned 33,076 shares of the company’s stock, valued at approximately $7,812,220.44. This represents a 47.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Michelle Greene sold 11,650 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the transaction, the insider owned 10,330 shares of the company’s stock, valued at approximately $2,434,987.60. The trade was a 53.00% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 210,271 shares of company stock worth $49,626,657. Company insiders own 0.12% of the company’s stock.

About Cardinal Health

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.